Nature Publishing and the Australasian Society for Immunology (ASI) announce that NPG will publish in partnership with the Society its flagship journal, Immunology and Cell Biology, from January 2007
Tokyo-based NPG publishing director David Swinbanks said: "Immunology and Cell Biology is a superb addition to the programme of partnerships between NPG Nature Asia-Pacific and key scientific and clinical organisations across the Asia-Pacific region.
"We are excited to be working with the Australasian Society for Immunology to further develop a journal with an already well-established reputation for quality.
"There is tremendous enthusiasm among members of the ASI for this partnership".
"We see it is a fantastic opportunity to bring exposure of our journal to a new level", president of ASI, Philip Hodgkin, said in Melbourne.
Chris Parish, long time editor of Immunology and Cell Biology further commented: "This represents a wonderful opportunity for ICB to develop partnerships with other immunology and molecular cell biology journals published by NPG, a process that will help to enhance the editorial content and international reputation of ICB".
Immunology and Cell Biology (ICB) has an illustrious 75 year history of publishing high-quality international research.
Its focus on the broad fields of immunology and cell biology and its status as one of the leading basic biological research journals in the Asia-Pacific region makes it an ideal addition to NPG's portfolio of journals.
This partnership is a part of a major initiative of NPG Nature Asia-Pacific, a newly formed division of NPG with offices in Tokyo, Hong Kong and Melbourne, in which it will partner with scientific societies in this region to produce high-quality journals.
ICB will be joining NPG's stable of highly respected journals in Immunology and Molecular Cell Biology, which include Nature Immunology, Nature Cell Biology, Nature Reviews Immunology, The EMBO Journal and Genes and Immunity.
This new partnership will provide many benefits for authors of ICB papers and readers of the journal.
Papers published in the journal will receive high exposure through nature.com, which currently has an average of 30 million page downloads per month, more press coverage and quick publication, including publication ahead of print.
ICB will be able to take advantage of NPG's strengths: top-class editorial expertise, pioneering technologies, innovative formats and world-class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.
Another key strength of NPG is its close relationship with the scientific community.
By working in partnership with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, NPG is the leading scientific publisher at finding innovative solutions to scientists' information needs, both for the Nature-branded publications and those, like ICB, published in partnership.
The Australasian Society for Immunology (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975.
The aim of the society is to encourage and support the discipline of immunology in the Australasian region.
It is a broadly-based society, embracing clinical and experimental, cellular and molecular immunology in humans and animals.
The society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas.
